Publicaciones en colaboración con investigadores/as de Imperial College London (1)

2019

  1. Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin

    Diabetes, Obesity and Metabolism, Vol. 21, Núm. 6, pp. 1506-1512